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life expectancy has been increasing in the united States for well over a cen-
tury. while some analysts, including the Social Security administration, have 
projected a continued rise over the next seven decades (Board of trustees 
2009), others have argued that the substantial rise in obesity could cause life 
expectancy to level off or decline within the first half of this century (olshan-
sky et al. 2005). Recent research on the joint effects of obesity and smoking 
on uS life expectancy forecasts that the negative effects of rising obesity will 
potentially overwhelm the positive effects gained from declining smoking 
rates, retarding increases in life expectancy (Stewart, Cutler, and Rosen 2009). 
the uS has witnessed substantial increases in the prevalence of obesity. adult 
obesity (body mass index [Bmi] ≥30.0 kg/m2) has more than doubled over 
the past three decades, and obesity among school-aged children (Bmi-for-age 
≥95th percentile) has tripled (Flegal et al. 2010; ogden et al. 2002). Projec-
tions of the effect of obesity on life expectancy, however, generally assume 
that the risk of death imposed by obesity has been and will remain stable 
(Stewart, Cutler, and Rosen 2009; olshansky et al. 2005).
a large number of studies have shown that class i obesity (Bmi 30.0–
34.9) and class ii/iii obesity (Bmi ≥35.0) have strong associations with mor-
tality (Prospective Studies Collaboration 2009; Hu et al. 2004; mokdad et al. 
2004; Fontaine et al. 2003; Peeters et al. 2003; allison et al. 1999; Calle et al. 
1999; manson et al. 1995). all of these studies, however, rely on mortality 
data collected before 1990. in contrast, research using more recent data has 
found that more moderate levels (class i) of obesity are not strongly associated 
with mortality (mehta and Chang 2009; Reuser, Bonneux, and willekens 
2009; Flegal et al. 2007a; Flegal et al. 2005) and that only a small proportion 
of excess deaths in the uS is attributable to obesity (mehta and Chang 2009). 
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For example, recent research on middle-aged adults estimates that less than 
5 percent of deaths in 1999 were attributable to obesity (Bmi ≥30.0) (mehta 
and Chang 2009). although numerous methodological differences likely 
contribute to prior divergent estimates, discrepancies may be partly explained 
by the fact that this relationship has weakened over time (mehta and Chang, 
in press, reviews additional methodological differences).
 a decrease in the association between obesity and mortality may be 
promoted by changes in health behaviors and improvements in medical 
care, particularly for cardiovascular disease (Cvd). obese persons have 
experienced substantial declines in high blood pressure, smoking, and to-
tal cholesterol since the 1960s (Gregg et al. 2005). For example, between 
1960–62 and 1999–2000, the prevalence of hypertension has decreased 
by 49 percent among the obese, and high cholesterol has decreased by 54 
percent. in fact, physicians may even be more aggressive with risk-factor 
modification among obese persons. Reductions in cholesterol have been 
proportionately greater for obese patients than for patients of normal weight 
(ibid.), and recent research finds that obese patients are more likely to 
receive recommended diabetes care than normal-weight patients (Chang, 
asch, and werner 2010). 
in addition to its importance in forecasting life expectancy, understand-
ing change over time in the magnitude of the association between obesity 
and mortality is also critical for estimating obesity’s contribution to current 
variations in national mortality patterns. the united States has a consider-
ably higher level of obesity and a lower life expectancy than most other 
high-income countries (Preston and Stokes in press). Findings from the 
recent national Research Council (nRC) report on the causes of longevity 
differences among high-income countries indicate that obesity accounts for 
approximately 41 percent and 67 percent of the shortfall in uS longevity 
among women and men, respectively (compared to the average of 12 other 
high-income countries) (national Research Council 2011). these estimates, 
however, are based on a set of relative risks for obesity derived from a study 
in which the mean year of death was 1986. when relative risks of obesity are 
derived from more recent data, the nRC report indicates that obesity accounts 
for approximately 20–30 percent of the uS shortfall in longevity. 
our objective is to investigate secular trends in the association between 
obesity and mortality in the united States. we rely on three long-standing uS 
data sources on health and mortality: (1) the Framingham Heart Study, (2) 
the national Health and nutrition examination Survey (nHaneS), and (3) 
the national Health interview Survey (nHiS). we compare periods of mortal-
ity that are non-overlapping and of similar duration within each data source 
and cover a time period extending from 1948 to 2006. we investigate trends 
for both all-cause mortality and cause-specific (Cvd, cancer, and non-Cvd/
non-cancer) mortality.
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Methods
Data
table 1 presents characteristics of the data. in order to examine trends, we 
sought data sources that followed independent cohorts over distinct time peri-
ods and were linked to mortality. we defined an “earlier” and “later” mortality 
period within each of our three data sources (Framingham, nHaneS, and 
nHiS) to examine change over time in the association between obesity and 
mortality. mortality follow-up for the two periods within each data source is 
non-overlapping in time, of comparable duration, and based on independent 
samples. the timelines are shown in Figure 1. we included individuals between 
ages 50 and 74 at study entry. 
Framingham Heart Study. the Framingham Heart Study is a multi-cohort 
study conducted by the national Heart, lung, and Blood institute (Kannel 
et al. 1979; drawber, meadors, and moore 1951). the study began in 1948 
with a sample of adults in Framingham, massachusetts. Beginning in 1971, 
the children of the original cohort and their spouses were enrolled. we used 
the original cohort for the earlier period and the offspring cohort for the later 
period. we included persons who reached age 50 in any of the first seven 
exams (1948–1962) of the original cohort and who reached age 50 in exams 
three to five (1985–1992) of the offspring cohort. we restrict entry ages in 
both Framingham datasets to ages 50–69 because no respondent in the origi-
nal cohort was above age 70 in the first exam. we also excluded earlier waves 
of the offspring cohort because body weight was only available in 5-pound 
intervals, precluding a precise calculation of Bmi. we followed deaths in the 
original cohort through 1970 and deaths in the offspring cohort through 2003. 
thus, the mortality periods covered were 1948–1970 (original cohort) and 
1985–2003 (offspring cohort). while the Framingham study is not nationally 
representative like the other data used in this analysis, it allows for the estima-
tion of obesity-related mortality risks during a relatively early period.
National Health and Nutrition Examination Survey. nHaneS is a nationally 
representative cross-sectional survey of the uS population conducted by the 
national Center for Health Statistics (nCHS). we used data from nHaneS i 
(1971–1975) for the earlier period and data from nHaneS iii (1988–1994) 
for the later period. For nHaneS i, we restricted our sample to a subset that 
was surveyed about smoking, which is a key confounder in the association 
between obesity and mortality. the mortality periods were 1971–1987 for 
nHaneS i and 1988–2006 for nHaneS iii.
National Health Interview Survey. nHiS is a nationally representative an-
nual cross-sectional survey of the uS population conducted by nCHS. For the 
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surveys and measured deaths through 1996 (the 1989 survey was excluded 
because data on smoking were unavailable). For the later period (Period 2), 
we pooled the 1997–2000 surveys and assessed mortality through 2006. For 
both periods, we restricted the analyses to subsamples that were administered 
a supplementary questionnaire on smoking. 
Measures
the nHaneS iii and nHiS data are linked to the national death index by 
nCHS. we use the 1992 nHaneS i epidemiologic Follow-up Study to obtain 
data on deaths in nHaneS i. deaths in the Framingham study are ascer-
tained by a panel of Framingham investigators and are available in the data. 
approximately 1 percent of respondents had insufficient data with which to 
ascertain mortality status. 
in cause-specific analyses, we examined three categories of deaths: 
Cvd, cancer, and non-Cvd/non-cancer. Cvd and cancer are leading causes 
of death in the united States (Jemal et al. 2005), and both are associated with 
obesity (Calle et al. 1999; Calle et al. 2003). For nHiS and nHaneS, deaths 
were classified according to the nCHS 113 Selected Causes of death recodes 
following Flegal et al. (2007a): cardiovascular disease (codes: 53–74), cancer 
(codes: 19–43), and non-Cvd/non-cancer (all other codes). we grouped 
deaths in the Framingham study into the same three categories using avail-
able data on causes of death. 
 weight status was modeled using standard categories: underweight 
(Bmi <18.5), normal (Bmi 18.5–24.9), overweight (Bmi 25.0–29.9), class 

















FIGURE 1   Timeline of follow-up periods in three US mortality studies
NOTE: The time span of each follow-up period is represented by the dotted lines.
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organization 2000; national Heart, lung, and Blood institute 1998). we 
combined class ii (Bmi 35.0–39.9) and class iii (Bmi ≥40.0) obese catego-
ries because of the small number of individuals in the samples who are class 
iii obese. the percentage of class iii obesity within the class ii/iii category 
remained relatively stable over the nHaneS periods (approximately 30 per-
cent), increased in the Framingham study (from 23 percent to 34 percent), 
and declined in the nHiS (from 27 percent to 21 percent). weight and height 
were clinically measured in the Framingham study and nHaneS and were 
self-reported in the nHiS. our previous work suggests that the estimated as-
sociation between obesity and mortality is not highly sensitive to potential 
bias from self-reported height and weight (mehta and Chang 2009).
Socioeconomic status is associated with Bmi and mortality (lantz et al. 
2010; Chang and lauderdale 2005; mujahid et al. 2005). we included both 
family income (quartiles) and education (<12 years, 12 years, 13–15 years, 
≥16 years). Family income quartiles were estimated using the distributions 
of family income in the baseline data. Family income was unavailable for the 
Framingham study, and the two highest education categories (13–15 and ≥16 
years) were combined owing to data availability. other covariates included 
sex, cigarette smoking (never, former, current <1 pack daily, 1 to <2 packs 
daily, and ≥2 packs daily), race/ethnicity (non-Hispanic white, non-Hispanic 
black, Hispanic, non-Hispanic other), and marital status (never married, mar-
ried, widowed/divorced/separated). For the Framingham data, we excluded 
marital status because it was not consistently available, and race/ethnicity 
was excluded because the cohorts are predominantly white. in the nHiS and 
nHaneS analyses, we additionally adjusted for region of residence in the uS 
(northeast, South, midwest, and west).
Statistical analysis
we estimated hazard ratios (HRs) for the Bmi categories from Cox proportion-
al hazard models using age as the time scale (Korn, Graubard, and midthune 
1997). each of the three data sources was analyzed separately. within each 
source, we pooled data from the two mortality periods and constructed a 0/1 
indicator variable for period, with the later period coded as 1. we estimated 
a model that included the covariates noted above and two-way interactions 
between each covariate and the period variable. the p values of the interac-
tion terms for the Bmi categories indicate whether there was a significant 
change between periods in their hazard ratios for mortality. Survivors were 
censored at the end of the follow-up period. For cause-specific mortality 
analyses, individuals who died from causes not under investigation were 
censored at the time of death. 
with exceptions noted below, we used list-wise deletion for missing 
covariates. the number of individuals with missing data on at least one 
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covariate in each data source was less than 5 percent, with the exception 
of education in the offspring cohort (8 percent) and income in nHaneS 
iii (8 percent) and nHiS (18 percent). Persons with missing education data 
in the Framingham study or missing income data in nHaneS or nHiS 
were included in the analyses using an indicator variable for missing data. 
within each data source, we estimated two additional models to check for 
potential bias from missing data on these variables. we assigned persons 
with missing data first to the highest category for that variable and then to 
the lowest. Results from these sensitivity analyses were highly similar to 
those we present, and our conclusions remained unchanged. in additional 
sensitivity analyses, we included interaction terms between Bmi categories 
and age at baseline, and alternatively between Bmi categories and attained 
age (age at exposure). these models also did not result in any meaningful 
changes to our findings.
estimates for nHiS and nHaneS reflect sample weighting and account 
for the complex survey designs. For nHiS and nHaneS i, we used sample 
weights applicable to the subsamples of individuals who were administered 
the supplementary questionnaire that included questions about smoking. For 
nHaneS iii, all adults were asked about smoking. Stata 11.0 was used for 
all analyses. this research was approved by the institutional Review Boards 
of the university of michigan and the university of Pennsylvania. 
Results
table 2 shows the unadjusted distributions of Bmi. For all data sources, 
both class i obesity and class ii/iii obesity increased significantly over time. 
For example, the prevalence of class i obesity increased from 14.4 percent 
in nHaneS i to 19.4 percent in nHaneS iii, and the prevalence of class ii/
iii obesity nearly doubled from 5.2 percent to 9.7 percent. the lower preva-
lence of class ii/iii obesity in nHiS Period 1 (1987–1991) than in nHaneS 
iii (1988–1994)—studies that cover a similar period—may reflect under-
reporting of weight among persons who were moderately and severely obese 
in nHiS. the prevalence of overweight remained relatively stable, although 
there was a modest and significant increase in the nHiS from 38.9 percent 
to 41.3 percent. 
table 3 shows unadjusted death rates overall and by Bmi category. Con-
sistent with population trends, overall mortality declined across time in all 
three data sources. with the exception of the underweight and overweight 
categories in nHaneS, declines in mortality are observed for most Bmi cat-
egories across time in the three data sources. the trend of declining mortality 
for class i obesity was statistically significant in all three data sources. For class 
ii/iii obesity, declines were significant in nHiS but not in the Framingham 
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table 4 presents results from the multivariate all-cause mortality mod-
els. the top panel shows main effects for the weight status categories, which 
denote hazard ratios for the earlier periods. the middle panel shows hazard 
ratios for the weight status/time period interactions, and the bottom panel 
shows hazard ratios for weight status in the later periods, which were obtained 
by multiplying the main and interaction hazard ratios. across all three data 
sources, the interaction effects for class i obesity were less than 1.0, indicating 
a decline over time in its association with mortality. in the earlier periods, 
class i obesity was associated with significantly higher mortality relative to 
normal weight, with hazard ratios of 1.27, 1.53, and 1.14 in the Framingham, 
nHaneS, and nHiS data, respectively. in the later period of each data source, 
however, the hazard ratios for class i obesity declined to approximately 1.0 
and were not statistically significant. Figure 2 shows the declining association 
between mortality and class i obesity over time. despite a significant positive 
association with mortality in the earlier period for all three data sources, no 
association is observed in the later period for any of the data. these declines 
were statistically significant in nHaneS and the nHiS. also noteworthy, the 
hazard ratios associated with underweight (Bmi <18.5) are higher than those 
associated with the two obese classifications.
TABle 4 Hazard ratios and 95 percent confidence intervals for all-cause 
mortality in three US mortality studies
 Framingham NHANeS NHIS
Main effects   Original cohort  NHANeS I Period 1 
(earlier period) 1948–1970 1971–1987  1987–1996
underweight (Bmi<18.5) 2.20* [1.17–4.14] 2.15*** [1.57–2.95] 1.72*** [1.50–1.97]
normal weight (18.5–24.9)  1.00 [Ref.] 1.00 [Ref.] 1.00 [Ref.]
overweight (25.0–29.9) 0.88 [0.75–1.05] 0.83* [0.70–0.98] 0.88*** [0.83–0.94]
Class i obese (30.0–34.9) 1.27* [1.02–1.59] 1.53** [1.19–1.97] 1.14** [1.05–1.24]
Class ii/iii obese (35.0+)  1.46 [1.00–2.13] 1.60** [1.16–2.21] 1.56*** [1.34–1.84]
Interaction effects 
underweight x period 1.26 [0.47–3.42] 0.90 [0.54–1.48] 0.94 [0.68–1.30]
overweight x period 0.99 [0.75–1.31] 1.20 [0.97–1.50] 0.91 [0.83–1.01]
Class i obese x period 0.77 [0.54–1.19] 0.63** [0.47–0.85] 0.85* [0.75–0.97]
Class ii/iii obese x period 1.27 [0.74–2.16] 0.97 [0.65–1.36] 0.81* [0.65–1.00]
Main x interaction effects  Offspring cohort NHANeS III Period 2 
(later period)  1985–2003 1988–2006 1997–2006
underweight (Bmi<18.5) 2.77* [1.28–6.00] 1.92** [1.30–2.84] 1.61** [1.21–2.16]
normal weight (18.5–24.9)  1.00 [Ref.] 1.00 [Ref.] 1.00 [Ref.]
overweight (25.0–29.9) 0.87 [0.70–1.09] 0.99 [0.87–1.14] 0.81*** [0.74–0.88]
Class i obese (30.0–34.9) 0.98 [0.74–1.29]  0.97 [0.81–1.15] 0.97 [0.88–1.07]
Class ii/iii obese (35.0+)  1.85** [1.27–2.69] 1.56*** [1.22–1.99] 1.26** [1.09–1.45]
* p<.05; ** p<.01; *** p<.001 
note: all models adjust for sex, cigarette smoking, and education. the nHaneS and nHiS analyses are further adjusted 
for family income, race/ethnicity, marital status, and uS region of residence. dates refer to time span of the mortality 
period. main effects indicate hazard ratios for the earlier period of each data source. Hazard ratios for later period were 
obtained by multiplying the main effects by the interaction effects (may not be exact because of rounding). 
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FIGURE 2   Trends in all-cause mortality hazard ratios between earlier
and later periods for class I obesity relative to normal BMI in three US
mortality studies
*p<.05; **p<.01; ***p<.001
NOTE: The time span of each follow-up period is represented by the dotted lines. 95 percent confidence
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we additionally found a significant decline in the association between 
mortality and class ii/iii obesity in nHiS. in Period 1, the hazard ratio for 
class ii/iii obesity was 1.56, which declined to 1.26 in Period 2. unlike class i 
obesity, class ii/iii obesity was associated with significant excess mortality in 
the later periods for all three data sources. Finally, we found no evidence of 
trends in the hazard ratios for the underweight and overweight categories. 
overweight was generally associated with lower mortality, a finding consis-
tent with prior studies (lantz et al. 2010; mehta and Chang 2009; Kulminski 
et al. 2008; Flegal et al. 2005; mcGee 2005).
table 5 presents results for cardiovascular disease mortality. Similar to 
results for all-cause mortality, class i obesity was associated with significantly 
higher Cvd mortality in the earlier periods, but not in the later periods. the 
strongest proportionate decline in excess risk was observed in nHaneS: 
class i obesity was associated with a hazard ratio of 1.82 in nHaneS i and 
1.18 in nHaneS iii. this change represents an 89 percent decline in excess 
risk. the excess risks for class i obesity declined by 63 percent in the nHiS 
and by 47 percent in the Framingham study. overweight was not associated 
with excess Cvd mortality in any period of investigation, and there were no 
TABle 5 Hazard ratios and 95 percent confidence intervals for 
cardiovascular disease mortality in three US mortality studies
 Framingham NHANeS NHIS
Main effects   Original cohort  NHANeS I Period 1 
(earlier period) 1948–1970 1971–1987  1987–1996
underweight (Bmi<18.5) 0.54 [0.08–3.87] 1.79* [1.08–2.98] 1.25 [0.98–1.59]
normal weight (18.5–24.9)  1.00 [Ref.] 1.00 [Ref.] 1.00 [Ref.]
overweight (25.0–29.9) 1.00 [0.80–1.25] 0.83* [0.65–1.05] 0.97 [0.88–1.08]
Class i obese (30.0–34.9) 1.53** [1.14–2.04] 1.82*** [1.30–2.55] 1.40*** [1.23–1.59]
Class ii/iii obese (35.0+)  2.13** [1.34–3.39] 1.68* [1.05–2.69] 1.80*** [1.47–2.21]
Interaction effects 
underweight x period 5.53 [0.33–92.97] 0.74 [0.30–1.79] 0.80 [0.46–1.38]
overweight x period 1.17 [0.67–2.07] 1.19 [0.86–1.65] 0.94 [0.79–1.12]
Class i obese x period 0.83 [0.42–1.66] 0.65* [0.42–1.00] 0.83 [0.68–1.01]
Class ii/iii obese x period 1.17 [0.46–2.99] 0.88 [0.48–1.61] 0.96 [0.69–1.32]
Main x interaction effects  Offspring cohort NHANeS III Period 2 
(later period)  1985–2003 1988–2006 1997–2006
underweight (Bmi<18.5) 2.99 [0.40–22.52] 1.32** [0.64–2.73] 0.99 [0.61–1.63]
normal weight (18.5–24.9)  1.00 [Ref.] 1.00 [Ref.] 1.00 [Ref.]
overweight (25.0–29.9) 1.18 [0.70–1.98] 0.98 [0.79–1.22] 0.91 [0.79–1.05]
Class i obese (30.0–34.9) 1.28 [0.69–2.38] 1.18 [0.89–1.55] 1.15 [0.99–1.35]
Class ii/iii obese (35.0+)  2.48* [1.10–5.61] 1.49 [1.02–2.16] 1.73*** [1.35–2.22]
* p<.05; ** p<.01; *** p<.001 
note: all models adjust for sex, cigarette smoking, and education. the nHaneS and nHiS analyses are further adjusted 
for family income, race/ethnicity, marital status, and uS region of residence. dates refer to time span of the mortality 
period. main effects indicate hazard ratios for the earlier period of each data source. Hazard ratios for later period were 
obtained by multiplying the main effects by the interaction effects (may not be exact because of rounding).
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significant trends for this category. our assessment of cancer and non-Cvd/
non-cancer mortality detected no significant time trends in the hazard ratios 
for the overweight or obese groups (results not shown). 
Discussion
our objective was to investigate whether the association between obesity and 
mortality in the united States has changed over time by comparing estimates 
across non-overlapping time periods of similar length within three well-
known data sources. For class i obesity, which represents by far the largest 
proportion of obesity, we found substantial weakening of the association over 
time in all three data sources examined. while class i obesity was significantly 
associated with higher all-cause mortality relative to normal weight status 
in the earlier periods, this excess risk was eliminated by the later periods. as 
expected, these changes may be attributable to declines in the association 
between class i obesity and cardiovascular mortality. in contrast to class i 
obesity, class ii/iii obesity remained significantly associated with mortality 
in the later periods in all data three sources, and the existence of a trend is 
less clear. while the nHiS showed a 54 percent decline in excess mortality 
associated with class ii/iii obesity relative to normal weight, the nHaneS and 
Framingham data showed no evidence of a trend.
these reductions in the magnitude of the association between obesity 
and mortality have occurred during a period when obesity levels in the united 
States have risen substantially (Flegal et al. 2010; ogden et al. 2002). our 
findings suggest that obesity would be having a much larger influence on 
present-day uS mortality had the association between obesity and mortality 
not been lowered. we can use attributable-risk calculations to broadly as-
sess the extent to which a declining trend may have benefited uS mortality 
patterns.1 Calculations show that approximately one-quarter of all deaths to 
middle-aged adults in 2003–2004 are attributable to obesity when the risks 
from nHaneS i (1971–1987) are used. in contrast, if risks from the more 
recent nHaneS iii period (1988–2006) are used, only about one-tenth of 
all deaths are attributable to obesity in 2003–2004. Furthermore, mortality 
attributable to obesity drops to 5 percent if we use risks from the most recent 
period (nHiS Period 2, 1997–2006). 
the research cited at the beginning of this article suggested that rising 
obesity levels may threaten future gains in uS life expectancy. Recent projec-
tions by both olshansky et al. (2005) and Stewart, Cutler, and Rosen (2009) 
used earlier nHaneS data to estimate the association between obesity and 
mortality, estimates that those authors then applied to life expectancy pro-
jections. thus, prior projections did not account for possible secular changes 
in the obesity/mortality association and assumed that estimates from earlier 
periods are directly applicable to current conditions. Similarly, estimates of 
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the contribution of changing risk factors (e.g., cholesterol, smoking, blood 
pressure, and obesity) to declines in deaths from coronary heart disease 
(CHd) from 1980 to 2000 relied on data from earlier periods to estimate the 
association between obesity and CHd mortality, potentially overestimating 
the countervailing effects of obesity (Ford  et al. 2007). 
Since the 1980s, the united States has experienced substantial declines 
in cardiovascular disease mortality (Jemal et al. 2005). our findings sug-
gest that obese persons have benefited from these mortality improvements, 
perhaps more so than persons of normal weight. overall reductions in Cvd 
mortality have been attributed to pharmaceutical innovations, the increased 
effectiveness of invasive medical treatments, and behavioral changes (Ford 
et al. 2007; Cutler and Kadiyala 2003). we accounted for changes in smoking 
behaviors, so the reductions we observed are likely driven by other factors. 
along with advances in the treatment of cardiovascular disease, improved 
control of its risk factors may be a contributing explanation. as previously 
noted, obese persons have experienced declines in high blood pressure and 
total cholesterol over the past few decades (Gregg et al. 2005). in fact, the 
prevalence of high cholesterol has dropped further for the obese compared to 
those with a Bmi<25.0 (ibid.). moreover, recent research suggests that physi-
cians may be more aggressive in risk-factor modification for obese patients 
with diabetes relative to normal-weight patients with diabetes (Chang, asch, 
and werner 2010). Changes in social norms and obesity-related stigma could 
also play a role. large increases in the prevalence of obesity over time may 
lead to improvements in the relative status of persons who are mildly obese, 
potentially attenuating social isolation and discrimination in employment and 
health care as their body type becomes more commonplace. 
while we report favorable trends with respect to obesity’s association 
with mortality, increased survival among obese persons may have come at 
a cost of increasing levels of disability (alley and Chang 2007). Recent work 
suggests that obesity’s association with disability increased among older adults 
between 1988–1994 and 1999–2004, potentially because people are now liv-
ing longer with obesity (ibid.). indeed, declining mortality among the obese 
may be contributing to the increase in prevalence of obesity observed at older 
ages (doshi, Polsky, and Chang 2007). Furthermore, recent studies examining 
the simultaneous association of obesity with disability and mortality report 
that obesity is more likely to shorten disability-free life expectancy than over-
all life expectancy at middle and older ages (Reuser, Bonneux, and willekens 
2009; al Snih et al. 2007; Reynolds, Saito, and Crimmins 2005). thus, efforts 
to improve the health of the obese population may have been more success-
ful at increasing life span than at reducing obesity-related disability. obesity 
continues to have important public health and economic consequences. 
the trends in the association between obesity and mortality we observed 
between nHaneS i and iii are consistent with estimates by Flegal et al. 
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(2007a; 2005), who also showed that estimates of relative risk of death from 
nHaneS ii (1976–1980 baseline) were lower than those from nHaneS i. in 
a letter to The New England Journal of Medicine, Calle, teras, and thun (2005) 
reported no decline in the obesity/mortality association for nonsmokers across 
three periods between 1982 and 1998 using the Cancer Prevention Study 
ii. this study followed a single cohort with Bmi measured in 1982. thus, 
comparisons of estimates across periods were based on the same set of indi-
viduals. in contrast, our study measured trends across independent samples 
that had a similar mean age at baseline and a comparable length of mortal-
ity follow-up. Confidence in our findings is further increased by testing for 
statistical significance in the observed trends, by the use of non-overlapping 
follow-up periods, and by the finding of a consistent set of results from three 
independent data sources. 
nevertheless, uncertainty remains about the extent to which obesity 
currently increases the risk of dying. an analysis of an international sample 
of white adults by Berrington de Gonzalez et al. (2010), which incorporates 
data covering 1976–2002, suggests that mild levels of obesity are associated 
with excess mortality compared to a Bmi within the normal range. this 
analysis combined multiple prospective studies primarily from the united 
States, though none were nationally representative. Further research exam-
ining whether a decline has occurred in the association between obesity and 
mortality in other large-scale datasets would be enlightening. 
our study has limitations. First, sample size considerations precluded our 
examining narrower time periods in the Framingham study and nHaneS. 
Second, our ability to detect significant changes in the hazard ratios of persons 
with class ii/iii obesity may have been limited by the very low prevalence of 
this category in earlier periods. nonetheless, we detected significant declines for 
all-cause mortality in the nHiS, which covered more recent periods and offers 
the largest sample size. Finally, debate continues over the extent to which the 
obesity/mortality association is confounded by preexisting diseases (mehta and 
Chang in press; Flegal et al. 2011; Hu 2008; Flegal et al. 2007b; manson et al. 
2007). we did not adjust for prevailing diseases because they may lie on the 
causal pathway between obesity and death. For nHaneS and nHiS, however, 
sensitivity analyses that adjusted for overall self-rated health, and sensitivity 
analyses limited to persons reporting excellent, very good, or good overall 
health, yielded results that are highly similar to those we reported above and 
that are consistent with prior studies indicating that preexisting illnesses do 
not substantially bias the association between obesity and mortality (Flegal et 
al. 2011; mehta and Chang 2009; al Snih et al. 2007; Flegal et al. 2007b). Self-
rated health was unavailable in the Framingham study.
in sum, the association between obesity and mortality, as well as the 
long-term influence of obesity on population health in the united States, 
remains highly controversial. while numerous methodological differences 
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likely contribute to divergent estimates of the association between obesity and 
mortality (mehta and Chang in press), our findings suggest that the period 
of mortality follow-up is an important source of variation, and that findings 
based on data from earlier periods may lead to an over-estimation of the cur-
rent association. Projections of the future influence of obesity on population 
health and longevity are critical to assessing future health care expenditures 
and public costs, including the solvency of age-based entitlement programs 
such as Social Security and medicare. the increased prevalence of obesity 
among children and adolescents, along with an increase in severe obesity 
among adults, will likely have a substantial impact on future associations 
between obesity and mortality.
Note
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